EnteroMedics' Unattributed VC - III Round

EnteroMedics raised a round of funding on September 23, 2005. Investors include Western Technology Investment.

EnteroMedics (NASDAQ: ETRM) has developed vBloc® vagal blocking therapy, a unique, broadly patented therapeutic approach to treat a range of gastrointestinal and metabolic diseases. vBloc® is a firs…

Articles about EnteroMedics' Unattributed VC - III Round: